Compared to Estimates, Ventas (VTR) Q4 Earnings: A Look at Key Metrics

Core Insights - Ventas reported $1.29 billion in revenue for Q4 2024, a year-over-year increase of 10.5%, with an EPS of $0.81 compared to -$0.21 a year ago, indicating significant improvement in profitability [1] - The revenue exceeded the Zacks Consensus Estimate of $1.26 billion by 2.23%, and the EPS also surpassed the consensus estimate of $0.80 by 1.25% [1] Revenue Breakdown - Rental income from outpatient medical & research portfolio was $216.20 million, slightly below the estimated $220.75 million, reflecting a year-over-year decrease of 2.6% [4] - Rental income from triple-net leased properties was $157.40 million, exceeding the estimate of $151.56 million, showing a year-over-year increase of 1.4% [4] - Resident fees and services generated $896.36 million, surpassing the estimated $850.11 million, with a notable year-over-year increase of 15.6% [4] - Total rental income reported was $373.60 million, slightly above the average estimate of $372.31 million [4] - Third-party capital management revenues were $4.34 million, below the estimated $4.63 million, representing a year-over-year decrease of 0.3% [4] - Interest and other income reached $8.31 million, exceeding the estimate of $5.60 million, with a significant year-over-year increase of 41.1% [4] - Income from loans and investments was $4.45 million, surpassing the estimated $2.56 million, reflecting a substantial year-over-year increase of 178% [4] Stock Performance - Ventas shares returned +2.5% over the past month, while the Zacks S&P 500 composite increased by +4.3%, indicating underperformance relative to the broader market [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the market in the near term [3]